Navigation Links
Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years
Date:12/10/2009

The ACHDC was the first medical center in the country specifically established to treat adolescents and adults and is today the largest of its kind in California. Today, the ACHDC has more than 3,000 patients in its registry.

(PRWEB) December 10, 2009 -- The Hertz Family Foundation of Santa Monica has announced that total contributions now exceed $2 million over the ten-year lifetime of the annual campaign to support the Ahmanson/UCLA Adult Congenital Heart Disease Center (ACHDC). The Hertz family has led the ACHDC annual fundraiser ever since its inception in 1999.
   
The ACHDC was the first medical center in the country specifically established to treat adolescents and adults and is today the largest of its kind in California. The ACHDC has nearly 400 patients when it opened its doors in 1981. Within five years, this figure increased to 700. Today, the ACHDC has more than 3,000 patients in its registry.

Said Judah Hertz, founder and CEO of Hertz Investment Group, and chairman of the annual appeal since 1999: “Each year for the past ten years, my family has been privileged to lead this extraordinary campaign. A generation ago, the diagnosis of congenital heart disease meant that young lives were permanently restricted and cruelly shortened. With the extensive medical and surgical innovations of the past 30 years and high-quality care received in childhood, 85% of children born with CHD in the United States will survive to adulthood. In fact, there are now more adults living with CHD than there are children – but the ACHDC at UCLA is one of very few centers nationwide that provide expert treatment for this growing adult population.”

In addition to its emphasis on the highest quality of patient care, the center is also a major training and research facility for medical and pediatric house officers, medical and pediatric cardiologists, and visiting cardiologists from the United States and abroad. The center offers an advanced fellowship for cardiologists with a career interest in congenital heart disease in adults.

Said Dr. John Child, ACHDC director: “The generosity of Judah Hertz and the Hertz Investment Group over the past decade helps to sustain the important programs and services we offer. The center is dependent on its own financial resources and the support of the annual appeal also makes it possible for us to support the Center’s world-class faculty and staff and to meet the needs of our growing patient population.”

About the Hertz Family Foundation

The Judah Hertz family makes project-specific grants and supports capital campaigns and unrestricted gifts to a select group of grantee organizations. There is a preference for projects promoting medical research, Jewish education and Jewish culture in Los Angeles, New York, and Israel.

In 2009, Judah Hertz and his family have met pledges of more than $2 million made to programs in Israel including:

 
  • Aleh – Israel’s largest network of residential facilities for children with severe physical and rehabilitative care.
  • Ohr Somayach – a yeshiva based in Jerusalem, catering mostly to Jewish college-age men, who excel in their secular studies and are interested in returning to and learning more intensively about Judaism.
  • Simon Wiesenthal Museum of Tolerance Jerusalem – a new complex under construction, which is dedicated to promoting coexistence in Jerusalem, to include a conference center, theater, and two museums.

Judah Hertz has also led successful efforts to raise more than $2 million for the Ahmanson / UCLA Adult Congenital Heart Disease Center, the first and one of the largest facilities dedicated to providing care to the growing number of patients with congenital heart disease who reach adulthood.

The Hertz family is an enthusiastic supporter of several additional organizations focused on teaching Jewish scripture and the family provided support in 2009 to a group of Jewish institutions of secondary and higher education.

Significant educational grants in 2009 were made by the Hertz family to Yeshiva Gedolah, the Bais Yaakov School for Girls, Merkaz Hatorah Community Kollel , and Etta Israel Center in Los Angeles; Gerer Yeshiva Mesifta in New York City; Yeshiva Mir Jerusalem; the Ner Israel Rabbinical College in Baltimore; Ichud Mosdos Gur in Brooklyn; and the Rabbinical Council of California.

The family also regularly funds selected medical programs, including significant 2009 grants to UCLA / Ahmanson, Maayanei Hayeshua' Hospital in Israel, AmfAR Foundation for Aids Research, and the Leukemia & Lymphona Society.

For more information, visit us at www.hertzgroup.com on the Web.

###

Read the full story at http://www.prweb.com/releases/2009/12/prweb3322104.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Engineers demonstrate first room-temperature semiconductor source of coherent Terahertz radiation
2. Researchers at Leeds mine the Terahertz gap
3. AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
4. 34th Annual Hutch Holiday Gala Raises More Than $7 Million For Cancer Research
5. Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH)
6. NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference
7. Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference
8. Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
9. Cell Therapeutics, Inc. (CTI) to Present at 21st Annual Piper Jaffray Health Care Conference
10. Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference
11. Spherix Announces Results of Annual Shareholders Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... 5, 2016  Eisai Inc. announced today final ... of rufinamide, which were presented at the 2016 ... held from December 2-6 in Houston, ... tolerability and cognitive data showed that patients who ... and tolerability profiles, cognitive development and behavior, compared ...
(Date:12/4/2016)... SAN DIEGO , Dec. 3, 2016  In ... Society of Hematology (ASH) Annual Meeting and Exposition in ... advanced biomedical engineering methods to improve the delivery of ... conditions. These new methods are designed to carry therapies ... are needed most, which could provide a substantial advantage ...
(Date:12/2/2016)... Calif. , Dec. 2, 2016 Amgen (NASDAQ: ... AGN ) today announced the submission of a Marketing Authorization ... 215, a biosimilar candidate to Avastin ® (bevacizumab). The ... submitted to the EMA. "The submission of ... Amgen seeks to expand our oncology portfolio," said Sean ...
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ... pneumatic tube systems for North American hospitals, will present its chain-of-custody solution for ... and Exhibition in Las Vegas, Nev., Dec. 4-8, 2016. , Aerocom has a ...
Breaking Biology Technology:
(Date:11/17/2016)... Global Market Watch: Primarily supported by ... Banks and Academics) market is to witness a value of ... the highest Compounded Annual Growth Rate (CAGR) of 10.75% is ... analysis period 2014-2020. North America is ... Europe at 9.56% respectively. Report ...
(Date:11/16/2016)... Nov. 16, 2016 Sensory Inc ., ... security for consumer electronics, and VeriTran , ... retail industry, today announced a global partnership that ... to authenticate users of mobile banking and mobile ... software which requires no specialized biometric scanners, ...
(Date:11/15/2016)... DUBLIN , Nov 15, 2016 Research ... - Global Forecast to 2021" report to their offering. ... ... reach USD 16.18 Billion by 2021 from USD 6.21 Billion in ... Growth of the bioinformatics market is driven by ...
Breaking Biology News(10 mins):